A detailed history of Exchange Traded Concepts, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 41,632 shares of RPTX stock, worth $143,214. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,632
Previous 54,585 23.73%
Holding current value
$143,214
Previous $257,000 46.69%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$3.02 - $4.7 $39,118 - $60,879
-12,953 Reduced 23.73%
41,632 $137,000
Q1 2024

Apr 15, 2024

BUY
$4.53 - $8.41 $185,730 - $344,810
41,000 Added 301.8%
54,585 $257,000
Q4 2023

Jan 05, 2024

BUY
$3.22 - $11.79 $11,092 - $40,616
3,445 Added 33.97%
13,585 $99,000
Q3 2023

Oct 18, 2023

SELL
$8.16 - $13.01 $10,648 - $16,978
-1,305 Reduced 11.4%
10,140 $122,000
Q2 2023

Jul 20, 2023

BUY
$8.63 - $12.53 $98,770 - $143,405
11,445 New
11,445 $121,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $144M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.